Technical Analysis for SCLX - Scilex Holding Company
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.97 | 1.16% | 0.01 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
50 DMA Resistance | Bearish | 1.16% | |
20 DMA Support | Bullish | 1.16% | |
Wide Bands | Range Expansion | 1.16% | |
Fell Below 50 DMA | Bearish | 3.14% | |
Wide Bands | Range Expansion | 3.14% | |
Crossed Above 50 DMA | Bullish | -2.37% | |
New Uptrend | Bullish | -2.37% |
Alert | Time |
---|---|
Possible NR7 | about 17 hours ago |
50 DMA Resistance | about 19 hours ago |
Rose Above Previous Day's High | about 20 hours ago |
Rose Above 50 DMA | about 20 hours ago |
1.5x Volume Pace | about 20 hours ago |
Get a Trading Assistant
- Earnings date: Unknown
Scilex Holding Company Description
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Pain Organ Systems Pharmaceutical Products Opioids Chronic Pain Pain Management Acute Pain Acute And Chronic Pain Palliative Care Nociception
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.63 |
52 Week Low | 0.7316 |
Average Volume | 1,484,050 |
200-Day Moving Average | 1.32 |
50-Day Moving Average | 0.97 |
20-Day Moving Average | 0.90 |
10-Day Moving Average | 0.95 |
Average True Range | 0.11 |
RSI (14) | 52.61 |
ADX | 26.13 |
+DI | 27.86 |
-DI | 14.46 |
Chandelier Exit (Long, 3 ATRs) | 0.81 |
Chandelier Exit (Short, 3 ATRs) | 1.09 |
Upper Bollinger Bands | 1.04 |
Lower Bollinger Band | 0.76 |
Percent B (%b) | 0.75 |
BandWidth | 32.13 |
MACD Line | 0.00 |
MACD Signal Line | -0.02 |
MACD Histogram | 0.0166 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.06 | ||||
Resistance 3 (R3) | 1.06 | 1.04 | 1.05 | ||
Resistance 2 (R2) | 1.04 | 1.01 | 1.04 | 1.04 | |
Resistance 1 (R1) | 1.00 | 1.00 | 1.02 | 1.00 | 1.04 |
Pivot Point | 0.98 | 0.98 | 0.99 | 0.98 | 0.98 |
Support 1 (S1) | 0.94 | 0.95 | 0.96 | 0.94 | 0.91 |
Support 2 (S2) | 0.92 | 0.94 | 0.92 | 0.90 | |
Support 3 (S3) | 0.88 | 0.92 | 0.90 | ||
Support 4 (S4) | 0.88 |